Investigating the rate of surgical site infection in two methods of continuous and discrete sutures for primary wound closure in gastric and intestinal surgeries at the independent educational-therapeutic center Velayat in Qazvin: A randomized clinical trial study
Not Applicable
Recruiting
- Conditions
- Infection at the surgical suture site.Infection following a procedureT81.4
- Registration Number
- IRCT20230826059259N1
- Lead Sponsor
- Qazvin University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 154
Inclusion Criteria
Patients undergoing gastric and intestinal surgery
Age range 18-80
Exclusion Criteria
Having diabetes
Immune system diseases
History of gastrointestinal surgery
Pregnancy
Smoking, drugs and alcohol
Hypoproteinemia
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Accumulation of pus under the skin. Timepoint: From the time of completion of surgery to thirty days after that. Method of measurement: Clinical examination by a doctor.;Active secretions from the wound surface. Timepoint: From the time of completion of surgery to thirty days after that. Method of measurement: Clinical examination by a doctor.;Leukocytosis (white blood cells less than 4500). Timepoint: From the time of completion of surgery to seven days after that. Method of measurement: CBC test.;Pain at the wound site. Timepoint: From the time of completion of surgery to thirty days after that. Method of measurement: McGill pain questionnaire.;Fever. Timepoint: From the time of completion of surgery to thirty days after that. Method of measurement: Clinical examination by a doctor.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link suture technique to surgical site infection (SSI) risk in gastrointestinal surgeries?
How does continuous suture compare to discrete suture in reducing SSIs in gastric/colorectal procedures per IRCT20230826059259N1?
Are biomarkers like IL-6 or CRP predictive of SSI outcomes in primary wound closure using IRCT20230826059259N1 methods?
What adverse events are associated with continuous vs. discrete suture techniques in Qazvin University's SSI trial?
How do antimicrobial suture coatings or combination wound care strategies compare to IRCT20230826059259N1's suture methods for SSI prevention?